Sage Journals: Discover world-class research

Open access

Research article

First published 2018-7

High prevalence and indexes of anti-John Cunningham virus antibodies in a cohort of Chinese patients with multiple sclerosis

Alexander Lau, Wei Qiu, Allan Kermode [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Letter

First published 2020-1

Serum anti-John Cunningham virus antibody seroprevalence and index among Japanese patients with neuromyelitis optica spectrum disorders

Shinji Aoyama, Masahiro Mori, Akiyuki Uzawa [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2023-10

Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients

Auli Verkkoniemi-Ahola, Päivi Hartikainen, Katja Hassi [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2015-10

Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy

Anke Vennegoor, Johannis A van Rossum, Chris H Polman [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2021-7

The effect of tonsillectomy on John Cunningham virus serological status in multiple sclerosis patients: A retrospective case–control study

Mirla Avila, Annette Okai, Smathorn Thakolwiboon [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2015-4

JC virus antibody status in a pediatric multiple sclerosis cohort: Prevalence,conversion rate and influence on disease severity

Peter Huppke, Hanna Hummel, David Ellenberger [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2024-6

The impact of social distancing measures on anti–JC virus serostatus changes before and during the COVID-19 pandemic in US patients with multiple sclerosis

Stephen C Krieger, Susie Sinks, Furong Huang [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2021-10

The results of a 24-month controlled,prospective study of relapsing multiple sclerosis patients at risk for progressive multifocal encephalopathy,who switched from prolonged use of natalizumab to teriflunomide

Stanley Cohan, Tiffany Gervasi-Follmar, Aneesh Kamath [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2015-12

Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis

Rebekka Kohlmann, Anke Salmen, Andrew Chan [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2022-7

Immune cell subset profiling in multiple sclerosis after fingolimod initiation and continued treatment: The FLUENT study

Yang Mao-Draayer, Jeffrey A Cohen, Amit Bar-Or [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Search results